Showing results (1571-1580 of 1,729) with videos related to
Sort By:
Pageof 173
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomesLucy Haggstrom, Yeh Chen Lee, Clare Scott, et al.The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.Journal of Neurosurgery. Pediatrics|October 29, 2022
Developing consensus for the management of pediatric cervical spine disorders and stabilization: a modified Delphi studyYosef M Dastagirzada, Nikita G Alexiades, David B Kurland, et al.Bioanalysis|November 20, 2012
Recommendations on biomarker bioanalytical method validation by GCCRichard Hougton, Dominique Gouty, John Allinson, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial designMelisa Guelhan Inci, Jalid Sehouli, Eva Schnura, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 22, 2024
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomesLucy Haggstrom, Yeh Chen Lee, Clare Scott, et al.Nature Cancer|June 6, 2025
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumorsDongsheng Yuan, Robin Jugas, Petra Pokorna, et al.Cancer Immunology Research|October 11, 2019
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGFMariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, et al.Pageof 173